Sinopharm : Election of Language and Means of Receipt of Corporate Communication

(A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國控股份有限公司)

（Stock Code：01099）

23 April 2021

Dear Shareholder

Letter to H-share shareholders -

Election of Language and Means of Receipt of Corporate Communication

Pursuant to Rule 2.07A and 2.07B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and the articles of association of Sinopharm Group Co. Ltd. (the "Company" or "we"), we write to ascertain your preference as to the language and means of receipt of the Corporate Communication(Note) of the Company in the future.

You may choose to receive future Corporate Communication of the Company either:

1. both Chinese and English versions in printed form; or
2. only an English version in printed form; or
3. only a Chinese version in printed form; or
4. by means of the Company's website atwww.sinopharmgroup.com.cn(the "Website Version") in lieu of receiving printed copies and receiving a notification letter of the publication of the Corporate Communication on the Company's website,

by completing the enclosed Reply Form and returning it by post, using the mailing label in Reply Form (if you post in Hong Kong), or hand delivery to the Company c/o the H share registrar, Computershare Hong Kong Investor Services Limited (the "H Share Registrar") at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong.

If we do not receive your Reply Form or receive a response indicating the objection from you by 21 May 2021 and until you inform the Company c/o the H Share Registrar by reasonable notice in writing or by email to its email address at sinopharm.ecom@computershare.com.hkaccording to the relevant laws and regulations, you are deemed to have consented to receiving the Website Version in lieu of receiving printed copies and only a notification letter of the publication of the Corporate Communication on the Company's website will be sent to you in the future.

You are encouraged to take advantage of accessing the Corporate Communication posted on the Company's website, which helps to protect the environment and, we believe, is a more convenient and prompt method of communication with shareholders. If you elect to receive the Corporate Communication by means of the Company's own website, we will send you a notification of the posting of the relevant Corporate Communication on the Company's website on the same day that the printed Corporate Communication is mailed to the other shareholders.

You are entitled at any time to change the language and means of receiving the Corporate Communication by reasonable notice in writing to the Company c/o the H Share Registrar either by post to its address at Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong or by email to its email address at sinopharm.ecom@computershare.com.hk. If you have chosen to receive the Corporate Communication of the Company by means of the Company's own website and have any difficulty in receiving or gaining access to the relevant Corporate Communication for any reason, we will promptly upon your request send the printed form of the same to you free of charge.

Please note that the printed English and Chinese versions of the Corporate Communication are available from the Company or the H Share Registrar upon request, and both versions are also available on the Company's website at www.sinopharmgroup.com.cnand the HKExnews website of The Stock Exchange of Hong Kong Limited at www.hkexnews.hk.

If you have any queries relating to this letter, please do not hesitate to call our enquiry hotline at 852-2862 8688 during business hours from 9:00 a.m. to 6:00 p.m., Monday to Friday, excluding public holidays.

Yours sincerely

For and on behalf of

Sinopharm Group Co. Ltd.

Yu Qingming

Chairman

Encl.

• The Company is registered as a non-Hong Kong company under Part XI of the Companies Ordinance (Chapter 32 of the Laws of Hong Kong) under its Chinese name and the English name "Sinopharm Group Co. Ltd."

Note: Corporate Communication (the "Corporate Communication") of the Company refers to any document issued or to be issued by the Company for the information or action of holders of any of its securities, including but not limited to (a) the directors' report, its annual accounts together with a copy of the auditors' report and, where applicable, its summary financial report; (b) the interim report and, where applicable, summary interim report; (c) a notice of meeting; (d) a listing document; (e) a circular; and (f) a proxy form.